Latest Interim Results News

Treasury Wine Estates delivered a robust 1H25 performance driven by luxury brands Penfolds and DAOU, offsetting softness in its premium and commercial portfolios. Despite strong earnings growth, the company lowers its full-year EBITS guidance, highlighting ongoing market headwinds.

Treasury Wine Estates has delivered a robust half-year performance with revenue climbing nearly 20% and profit surging 33%, driven by premiumisation and strategic acquisitions. The company also declared a higher interim dividend, signaling confidence in its growth trajectory.

Amotiv Limited’s interim results reveal a 34.3% decline in net profit despite a 2.3% revenue increase, driven by significant impairments and restructuring costs. The company declared a fully franked interim dividend of 18.5 cents per share.

Vulcan Steel Limited reported a challenging first half of FY25 with significant declines in revenue, EBITDA, and net profit, yet maintained a solid 10% return on capital employed and declared a cautious interim dividend.

Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.

Garda Property Group has reaffirmed its FY25 income return at 7.2 cents per security and upgraded its distribution payout ratio to 95% of FFO. The group plans to sell its North Lakes industrial site for $114 million and is marketing its Cairns Corporate Tower, aiming to reduce gearing and reposition as a focused industrial REIT.

Pinnacle Investment Management Group Limited has reported a remarkable 151% increase in net profit after tax for the first half of FY2025, driven by strong performance fees and significant growth in funds under management. The firm’s strategic international acquisitions and diversified affiliate platform underpin its robust outlook amid ongoing market uncertainties.

Pinnacle Investment Management Group Limited has reported a remarkable 150.5% increase in net profit for the half year ended 31 December 2024, alongside a 16.7% rise in revenues and a healthy interim dividend announcement.

Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.

Invion Limited has marked significant progress in its cancer treatment pipeline, dosing the first patient in a pivotal skin cancer trial and reporting encouraging prostate cancer results, while securing fresh funding to support ongoing development.

Connexion Mobility reports a robust half-year performance with 15% revenue growth and a 43% jump in net profit, driven by product innovation and expanding dealership engagement.

Clime Capital Limited has announced guidance for a March quarter dividend of at least 1.35 cents per share, fully franked, supported by strong retained profits and franking credits.